OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro

por Cummings, J, Arnold, V, Yarbrough, K, Didier, C, Levy, Y, Barré-Sinoussi, F, Scott-Algara, D
Publicado 2009

S100A9 protein is a novel ligand for the receptor CD85j and their interaction is implicated in the NK cell-mediated control of HIV-1 replication

por Moreno Nieves, UY, Arnold, V, Cummings, JS, Didier, C, Gilbert, A, Barré-Sinoussi, F, Scott-Algara, D
Publicado 2012

The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection

por Chevalier, MF, Petitjean, G, Didier, C, Girard, P, Meyer, L, Barré-Sinoussi, F, Scott-Algara, D, Weiss, L
Publicado 2012